Recent research trials surrounding the medication Retatrutide , specifically the high-dose formulation referred to as ZPHC, reveal a significant impact on physique reduction and linked metabolic factors. Experts posit that this innovative compound, affecting both GLP-1 and GIP pathways , could pr